Table 6.

Patients presented hypersensitivity

	Adverse reaction	Association	Severity	Outcome	Time to onset (days)	Sex	Age	Complications	Concomitant suspected products	Comment from physicians
1	Rash	Associated	Not serious	Ameliorated	61	Male	28	Factor IX deficiency, Hepatitis C, Atrial septal defect, Pulmonary hypertension	–
2	Vomiting, Malaise	Not ruled out	Not serious	Recovered	152	Female	32	Oesophageal candidiasis, Acute lymphocytic leukaemia	–
3	Rash, Pyrexia	Not ruled out	Not serious	Recovered	9	Male	46	Hepatitis B	LPV/rtv	Association with HIV infection, LPV/rtv and Epzicom cannot be ruled out.
4	Drug eruption	Not ruled out	Not serious	Ameliorated	13	Male	38	–	LPV/rtv	Association with HIV infection, LPV/rtv and Epzicom cannot be ruled out.

ddI, didanosine; d4T, stavudine; AZT, zidovudine; NVP, nevirapine; 3TC, lamivudine; LPV/rtv, lopinavir/ritonavir; TDF, tenofovir disoproxil fumarate; EFV, efavirenz.